US20030149113A1
(en)
*
|
2001-10-12 |
2003-08-07 |
Caplan Michael J. |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
US7205151B2
(en)
|
2001-06-20 |
2007-04-17 |
Metaproteomics, Llc |
Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
|
US20040115290A1
(en)
|
2001-06-20 |
2004-06-17 |
Tripp Matthew L. |
Modulation of inflammation by hops fractions and derivatives
|
US7270835B2
(en)
|
2001-06-20 |
2007-09-18 |
Metaproteomics, Llc |
Compositions that treat or inhibit pathological conditions associated with inflammatory response
|
US7718198B2
(en)
|
2001-06-20 |
2010-05-18 |
Metaproteomics, Llc |
Treatment modalities for autoimmune diseases
|
US7279185B2
(en)
|
2001-10-26 |
2007-10-09 |
Metaproteonics, Llc |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
|
ATE482696T1
(en)
*
|
2001-10-26 |
2010-10-15 |
Metaproteomics Llc |
CUCUMINOID COMPOSITIONS WITH SYNERGISTIC INHIBITION OF THE EXPRESSION AND/OR ACTION OF CYCLOOXYGENASE-2
|
US8158160B2
(en)
|
2001-11-13 |
2012-04-17 |
Eric Hauser Kuhrts |
Anti-inflammatory cyclooxygenase inhibitors
|
EP1527127B1
(en)
|
2002-07-05 |
2009-02-11 |
Exxonmobil Chemical Patents Inc. |
Functionalized elastomer nanocomposite
|
DE10245988B4
(en)
*
|
2002-10-01 |
2005-01-27 |
Dr. André Rieks, Labor für Enzymtechnologie GmbH |
New curcumin derivatives for use in cosmetics, pharmaceuticals and nutrition
|
AU2003270283A1
(en)
*
|
2002-10-01 |
2004-04-23 |
Dr. Andre Rieks - Labor Fur Enzymtechnologie Gmbh |
Novel curcumin/tetrahydrocurcumin derivatives for using in cosmetics, pharmaceuticals and for nutrition
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
WO2004080396A2
(en)
*
|
2003-03-07 |
2004-09-23 |
The University Of Texas Md Anderson Cancer Center |
Liposomal curcumin for treatment of cancer
|
US7968115B2
(en)
|
2004-03-05 |
2011-06-28 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of cancer
|
JP2005041817A
(en)
*
|
2003-07-23 |
2005-02-17 |
Japan Science & Technology Agency |
Curcuminoid glycoside and method for producing the same
|
US7205011B2
(en)
*
|
2003-11-14 |
2007-04-17 |
Board Of Regents, Acting For And On Behalf Of, University Of Arizona |
Anti-inflammatory activity of a specific turmeric extract
|
US8841326B2
(en)
|
2004-02-12 |
2014-09-23 |
Stc.Unm |
Therapeutic curcumin derivatives
|
US7914831B2
(en)
*
|
2004-02-27 |
2011-03-29 |
Metaproteomics, Llc |
Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
|
US8784881B2
(en)
*
|
2004-03-05 |
2014-07-22 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of diseases
|
US20080103213A1
(en)
*
|
2004-03-05 |
2008-05-01 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of neurofibromatosis
|
EP1824496A4
(en)
*
|
2004-11-17 |
2008-07-16 |
Joanne Mclaurin |
Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation
|
WO2007119108A2
(en)
*
|
2005-10-13 |
2007-10-25 |
Waratah Pharmaceuticals Inc. |
Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
|
US20070197452A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Mclaurin Joanne |
Treatment of amyloid-related diseases
|
NZ571181A
(en)
*
|
2006-03-09 |
2011-12-22 |
Waratah Pharmaceuticals Inc |
A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
|
US20110028719A1
(en)
*
|
2006-05-19 |
2011-02-03 |
Jacek Slon-Usakiewicz |
Screening methods for amyloid beta modulators
|
WO2008034244A1
(en)
*
|
2006-09-21 |
2008-03-27 |
Waratah Pharmaceuticals Inc. |
The combination of a cyclohexanehexol and a nsaid for the treatment of neurodegenerative diseases
|
US20080075671A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Di Mauro Thomas M |
Intranasally administering curcumin to the brain to treat alzheimer's disease
|
JP2010506836A
(en)
*
|
2006-10-12 |
2010-03-04 |
リサーチ ファウンデイション オブ ザ シティー ユニヴァーシティ オブ ニューヨーク |
Novel curcumin and tetrahydrocurcumin derivatives
|
WO2008051474A1
(en)
*
|
2006-10-19 |
2008-05-02 |
The Uab Research Foundation |
Water soluble curcumin-based compounds
|
JP2010510254A
(en)
*
|
2006-11-24 |
2010-04-02 |
ワラタ ファーマシューティカルズ, インコーポレイテッド |
Combination treatment for Alzheimer's disease and related neurodegenerative diseases
|
JP5124712B2
(en)
*
|
2006-12-28 |
2013-01-23 |
マイスターバイオ株式会社 |
Method for producing polyphenol glycoside
|
FR2913733B1
(en)
|
2007-03-14 |
2009-06-26 |
Technofan Sa |
FAN WITH MEANS OF FOLLOW-UP OF WEAR
|
ES2425264T3
(en)
*
|
2007-04-12 |
2013-10-14 |
Waratah Pharmaceuticals, Inc. |
Use of cyclohexanehexol derivatives in the treatment of eye diseases
|
WO2008124931A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
|
WO2008124930A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
|
WO2008124929A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF α-SYNUCLEINOPATHIES
|
US8383865B2
(en)
*
|
2007-04-17 |
2013-02-26 |
Codman & Shurtleff, Inc. |
Curcumin derivatives
|
JP2010524959A
(en)
|
2007-04-17 |
2010-07-22 |
コドマン・アンド・シャートレフ・インコーポレイテッド |
Nasal administration of curcumin in a helium gas bolus to treat Alzheimer's disease
|
WO2009023357A2
(en)
*
|
2007-05-25 |
2009-02-19 |
University Of Rochester |
Curcumin derivatives and their use as radioprotectors
|
US7745670B2
(en)
*
|
2008-06-27 |
2010-06-29 |
Codman & Shurtleff, Inc. |
Curcumin-Resveratrol hybrid molecule
|
US7985776B2
(en)
|
2008-06-27 |
2011-07-26 |
Codman & Shurtleff, Inc. |
Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
|
WO2010033580A2
(en)
|
2008-09-19 |
2010-03-25 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Curcumin conjugates for treating and preventing cancers
|
JP2012505162A
(en)
*
|
2008-10-09 |
2012-03-01 |
ワラタ ファーマシューティカルズ, インコーポレイテッド |
Use of scyllo-inositol for treating macular degeneration related disorders
|
US20100286585A1
(en)
*
|
2009-01-26 |
2010-11-11 |
Codman & Shurtleff, Inc. |
Shunt Delivery of Curcumin
|
US7723515B1
(en)
*
|
2009-01-26 |
2010-05-25 |
Codman & Shurtleff, Inc. |
Methylene blue—curcumin analog for the treatment of alzheimer's disease
|
KR101157995B1
(en)
*
|
2009-04-28 |
2012-06-25 |
차의과학대학교 산학협력단 |
Novel bis-3-hydroxy-4-methyl-phenyl Derivatives and Methods for Preparing the Same
|
US9446145B2
(en)
|
2009-12-02 |
2016-09-20 |
Research Foundation Of The City University Of New York |
Curcumin-antibody conjugates as anti-cancer agents
|
WO2011082290A2
(en)
|
2009-12-31 |
2011-07-07 |
Organomed Corporation |
Formulations from natural products, turmeric, and aspirin
|
WO2011106691A2
(en)
|
2010-02-26 |
2011-09-01 |
Research Foundation Of The City University Of New York |
Curcumin derivatives
|
KR20160074015A
(en)
|
2010-06-17 |
2016-06-27 |
캘리포니아 인스티튜트 오브 테크놀로지 |
Methods and systems for modulating hormones and related methods, agent and compositions
|
WO2012004744A2
(en)
|
2010-07-05 |
2012-01-12 |
Polymer Technologies International (Eou) |
Polymeric composition for ocular devices
|
US10449193B2
(en)
|
2011-06-03 |
2019-10-22 |
Signpath Pharma Inc. |
Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
|
US10258691B2
(en)
|
2014-06-03 |
2019-04-16 |
Signpath Pharma, Inc. |
Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies
|
US10532045B2
(en)
|
2013-12-18 |
2020-01-14 |
Signpath Pharma, Inc. |
Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
|
US10349884B2
(en)
|
2011-06-03 |
2019-07-16 |
Sighpath Pharma Inc. |
Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
|
GB2507884B
(en)
|
2011-06-03 |
2019-10-23 |
Signpath Pharma Inc |
Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
|
US10117881B2
(en)
|
2011-06-03 |
2018-11-06 |
Signpath Pharma, Inc. |
Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
|
US12004868B2
(en)
|
2011-06-03 |
2024-06-11 |
Signpath Pharma Inc. |
Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
|
US10238602B2
(en)
|
2011-06-03 |
2019-03-26 |
Signpath Pharma, Inc. |
Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
|
EP2945570A1
(en)
|
2013-01-15 |
2015-11-25 |
Dave, Jagrat Natavar |
Toric-diffractive lens
|
EP2983618B1
(en)
|
2013-04-10 |
2019-04-17 |
Dave, Jagrat Natavar |
Phakic lens device with openings and concentric annular zones
|
CN103396462A
(en)
*
|
2013-08-10 |
2013-11-20 |
湖州师范学院 |
Curcumin glucoside and preparation method and application thereof in treating Parkinson disease
|
JP6224966B2
(en)
*
|
2013-09-12 |
2017-11-01 |
ハウス食品グループ本社株式会社 |
Method for producing monoglycoside of curcuminoid
|
EP3071190A4
(en)
*
|
2013-11-22 |
2017-05-31 |
Signpath Pharma Inc. |
Intravenous synthetic curcumin (s-curcumin) for the treatment of proliferative disorders
|
US20170304047A1
(en)
|
2014-09-02 |
2017-10-26 |
Jagrat Natavar DAVE |
Intraocular lens customized for astigmatism or combined astigmatism and presbyopia
|
KR102181659B1
(en)
|
2016-04-27 |
2020-11-24 |
사인패스 파마 인코포레이티드 |
Prevention of drug-induced atrioventricular blockade
|
US10076552B2
(en)
|
2016-08-09 |
2018-09-18 |
DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. |
Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
|
EP4065152A1
(en)
|
2019-11-25 |
2022-10-05 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Trem-1 inhibitors for the treatment of vaso-occlusions and tissue injuries in patients suffering from sickle cell disease
|
US20240173376A1
(en)
|
2021-03-12 |
2024-05-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Trem-1 inhibitors for the treatment of marfan syndrome
|
CN113318116B
(en)
*
|
2021-06-17 |
2023-08-25 |
成都奥睿药业有限公司 |
Use of curcumin difluoro boron and its derivative
|
WO2023061946A1
(en)
|
2021-10-11 |
2023-04-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of trem-1 for predicting and preventing postoperative complications after cardiac surgery with cardiopulmonary by-pass
|